|
|
 |
|
|
|
Introduction
Filariasis is a mosquito
borne parasitic disease causing swelling
of the limbs, urogenital organs, breast
etc. with long-term disability. In Bangladesh
it is present now in 23 endemic districts,
mostly bordering India. About 20 million
is already infected, most of which are
incapacitated and another 30 million are
at risk of infection.
The disease can be eliminated by yearly
single dose of Tab.
|
|
Diethylcarbamazine &
Tab. Albendazole for successive 4-6 years
by Mass Drug Administration (MDA) as per
WHO guideline. The morbidity can also
be controlled by simple washing, hygiene,
physiotherapy and surgery in case of hydrocele.
Ministry of Health and Family Welfare
is committed to eliminating filariasis
by 2015 with global elimination of WHO
commitment by 2020.
Mass Drug Administration
(MDA) was started in Panchagar District
in October 2001 covering 0.91 million
population with 93% coverage. In 2002,
5.1 million were under MDA with 87.32%
coverage. In 2003 another 17.2 million,
in 2004, 25 million, in 2005, 50 million
and in 2006 another 70 million population
will be under MDA. Morbidity control activity
will also continue side by side.
|
 |
|
Status
of the LF Elimination programme
Mapping has been partly
completed resulting in 23 districts in
Divisions being designated as endemic
with Mf rates of up to 16%. The total
endemic population is estimated to be
70 million.
In 2001 Bangladesh covered
896,000 people in Panchagar district with
albendazole and DEC, achieving a coverage
of 95.5%. The programme then scaled up
and covered 4.9 million people in four
districts in 2002, with a coverage of
93.6%. The reported coverage has been
validated with independent
|
|
|
Highlights
|
|
The disease can be eliminated
by yearly single dose of Tab.
Diethylcarbamazine & Tab. Albendazole
for successive 4-6 years by Mass Drug
Administration (MDA) as per WHO guideline
|
|
Objectives
To reduce and interrupt transmission
of Lymphatic Filariasis by 2015 and prevent
recurrence of new infections
To reduce and prevent disabiltiy
associated with filariasis
|
|
Strategies
Social Mobilization - to build
awareness, activities are planned according
to local characteristics by local experts
and backed up, where possible, by local
political, religious and community leaders
To interrupt transmission using
mass drug administration
Morbidity control including self
help care for intensive local hygiene
Building and sustaining partnerships
Programme management by strengthening
management and technical capacity
Door to door drug distribution
strategy
|
|
|
assessments. The strategy for
mass drug administration is door-to-door by
health and family planning field staff and volunteers.
Drugs are also administered in schools, mosques,
cinemas, shopping complexes and bus stations,
using volunteers, boy scouts and girl guides.
The MDA is communicated to the population by
an extensive social mobilisation programme using
films, billboards, leaflets, audiocassettes,
posters and banners.
Training for disability prevention
programme was launched in Panchagar in 2001
and extended to Nilphamari district in 2002.
A total of 43 doctors were trained in disability
management techniques. In addition 60 doctors
were trained in hydrocelectomy in January 2003.
A Filaria hospital was constructed by an NGO
in Nilphamari district with a grant from the
JICA in 2002.
Goal: To eliminate Lymphatic
Filariasis from Bangladesh by 2015
Outcomes 2003 - 2007
The LF Elimination programme
aims to scale up to reach the full 70 million
people living in endemic areas with albendazole
and DEC mass drug administration by 2007.
|
YEAR
|
Nos. to be covered
by MDA
|
Remarks
|
|
2001
|
1 million
|
896,000 people
covered, coverage of 95.5% |
|
2002
|
5 million
|
Actual achieved
with 93.6% coverage |
|
2003
|
17 million
|
Approved by the
RPRG, tablets being shipped |
|
2004
|
30 million
|
|
|
2005
|
50 million
|
|
|
2006
|
70* million
|
|
|
2007
|
70* million
|
|
|
* or to the total population
at risk as ascertained after completion
of mapping in 2005.
|
Partnerships
The Bangladesh Ministry of
Health and Family Welfare initiated the LF elimination
programme in 2001 with assistance from AUSAID
and WHO and up scaled to cover 4 districts in
2002 with funding assistance from the Liverpool
School of Tropical Medicine, and WHO, plus albendazole
donated by GlaxoSmithKline. The supplies of
DEC were provided by WHO through a grant from
the Bill and Melinda Gates Foundation.
 |
Go
Back |
LAST
UPDATE:
|
|
|